Background 18F-fluoro-2-deoxy-glucose (18F-FDG) positron emission tomography (PET) is
a functional imaging modality based on glucose metabolism. The correlation between EGFR …

Objective Epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma are
involved in the tumorigenesis and regulation of cell metabolism via Akt signaling. F-18 …

Abstract [18F] fluoro‑2‑deoxyglucose (FDG) positron emission tomography (PET)‑computed
tomography (CT) is a functional imaging modality based on glucose metabolism. The …

The study objective was to retrospectively analyze the metabolic variables derived from 18 F-
fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography …

Background The purpose of this study was to investigate an association between EGFR
mutation status and 18F‐fluorodeoxyglucose positron emission tomography‐computed …

Tumor heterogeneity and changes in epidermal growth factor receptor (EGFR) mutation
status over time challenge the design of effective EGFR tyrosine kinase inhibitor (TKI) …

Purpose: This study assessed the ability of metabolic parameters from
18Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG …

Objectives To explore the value of multiple metabolic and heterogeneity parameters of 2-
deoxy-2-[fluorine-18] fluoro-D-glucose positron emission tomography/computed tomography …

Purpose The clinical implications of the metabolic parameters of 18F-fluorodeoxyglucose
positron emission tomography-computed tomography (18F-FDG PET/CT) in epidermal …

Simple Summary Epithelial growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are
the first-line therapy for patients with advanced-stage lung adenocarcinoma with EGFR …